Kat Arney

• Health & Medicine

'Johns Hopkins' cancer update emails are a hoax

Hoax emails about cancer risks and treatments are misleading and confusing, so don't pass them on. Here are the facts behind the claims. Hoax emails about cancer risks and treatments are misleading and confusing, so don't pass them on. Here are the facts behind the claims.

8 May 2015

• Health & Medicine

An important message for cancer patients: Beware the ‘cannabis oil’ scammers

We have become aware that scammers are tricking cancer patients and their families into handing over money for ‘cannabis oil’, yet receiving nothing in return. We have become aware that scammers are tricking cancer patients and their families into handing over money for ‘cannabis oil’, yet receiving nothing in return.

20 April 2015

• Science & Technology

From snapshot to family tree – writing the evolutionary rule book of cancer

Our scientists are piecing together cancer's family tree, uncovering clues that could help develop better treatments in the future. Our scientists are piecing together cancer's family tree, uncovering clues that could help develop better treatments in the future.

15 April 2015

• Health & Medicine
• Science & Technology

Unpicking the genetic ‘patchwork’ in ovarian cancer

Our researchers are investigating the genetic 'patchwork' underlying ovarian tumours, which will lead to more effective treatments in the future. Our researchers are investigating the genetic 'patchwork' underlying ovarian tumours, which will lead to more effective treatments in the future.

12 March 2015

• Science & Technology

Lethal Weapon Too: Using DNA repair processes to target cancer

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes. A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

24 February 2015

• Health & Medicine
• Science & Technology

The Enemy Within – 50 years of fighting cancer

We look back on the last 50 years of cancer research, where we were, what we've achieved and what's still left to do. We look back on the last 50 years of cancer research, where we were, what we've achieved and what's still left to do.

25 December 2014

• Health & Medicine
• Science & Technology

Coming ever closer – first PARP inhibitor licensed in Europe

Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK? Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?

24 October 2014

• Science & Technology

Andrew Biankin: We need a "We can do this!" attitude to pancreatic cancer

We speak to our pancreatic cancer expert Professor Andrew Biankin about how he's trying to change the picture for people with the disease. We speak to our pancreatic cancer expert Professor Andrew Biankin about how he's trying to change the picture for people with the disease.

10 September 2014

• Science & Technology

Bob Marley, genomics, and a rare form of melanoma

Our researchers in Manchester are using the power of DNA technology to study the genetic faults in the rare type of melanoma that killed Bob Marley. Our researchers in Manchester are using the power of DNA technology to study the genetic faults in the rare type of melanoma that killed Bob Marley.

20 August 2014